GlassScriptPhysician profile
Jamie Holz
NPI 1912565995
$6,371.63
in general payments reported to CMS, 2019-2025
14 companies · $495 in 2025
The $495 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,131 · 2022: $2,145 · 2023: $605 · 2024: $995 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,095.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $1,540.19 | 2021-2025 | Aristada, Lybalvi, Aristada Initio |
| Janssen Pharmaceuticals, INC | $1,012.93 | 2021-2024 | Invega Sustenna |
| Otsuka America Pharmaceutical, INC. | $546.70 | 2021-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Neurocrine Biosciences, INC. | $465.52 | 2021-2025 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $447.58 | 2024-2025 | Cobenfy, Opdivo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $414.32 | 2021-2024 | Caplyta |
| Abbvie INC. | $410.90 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $392.71 | 2021-2024 | Uzedy, Austedo Xr, Austedo |
| Lundbeck LLC | $371.26 | 2021-2024 | Abilify Asimtufii, Abilify Maintena |
| Indivior INC. | $258.51 | 2021-2024 | Perseris |
| Sunovion Pharmaceuticals INC. | $258.38 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $203.10 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $29.73 | 2025 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $19.80 | 2023 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Holz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.